Procyon Stock Today

PCYN Stock  USD 0.13  0.01  8.33%   

Performance

Fair

 
Weak
 
Strong

Odds Of Distress

Small

 
High
 
Low
Procyon is selling at 0.13 as of the 31st of January 2026; that is 8.33% increase since the beginning of the trading day. The stock's open price was 0.12. Procyon has about a 27 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 2nd of November 2025 and ending today, the 31st of January 2026. Click here to learn more.
Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States. The company was incorporated in 1987 and is based in Oldsmar, Florida. The company has 8.09 M outstanding shares. More on Procyon

Moving against Procyon Pink Sheet

  0.38BRK-A Berkshire HathawayPairCorr
  0.35MMM 3M CompanyPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Procyon Pink Sheet Highlights

Business ConcentrationDrug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Procyon [PCYN] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Procyon's market, we take the total number of its shares issued and multiply it by Procyon's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Procyon conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 8.09 M outstanding shares. Procyon currently holds about 1.04 M in cash with (229.46 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.13.
Check Procyon Probability Of Bankruptcy
Ownership Allocation
Procyon holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 65.0 pct. of Procyon outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event.
Check Procyon Ownership Details

Procyon Risk Profiles

Procyon Stock Against Markets

Procyon Pink Sheet Analysis Notes

About 65.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.77. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Procyon had not issued any dividends in recent years. Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States. The company was incorporated in 1987 and is based in Oldsmar, Florida. Procyon Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 19 people.The quote for Procyon is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Procyon contact Justice Anderson at 727 447 2998 or learn more at https://procyoncorp.com.

Procyon Investment Alerts

Procyon has some characteristics of a very speculative penny stock
The company reported the previous year's revenue of 4.84 M. Net Loss for the year was (209.79 K) with profit before overhead, payroll, taxes, and interest of 3.49 M.
Procyon currently holds about 1.04 M in cash with (229.46 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.13.
Roughly 65.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Applied Digital Kicks Off Coverage With Optimistic Outlook Check Out Wednesdays Four Key Initiations - Bitget

Procyon Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Procyon's market, we take the total number of its shares issued and multiply it by Procyon's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Procyon Profitablity

The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07.

Technical Drivers

As of the 31st of January, Procyon holds the Variance of 1.05, coefficient of variation of 812.4, and Risk Adjusted Performance of 0.0923. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Procyon, as well as the relationship between them.

Procyon Price Movement Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Procyon Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Procyon price patterns.

Procyon Outstanding Bonds

Procyon issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Procyon uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Procyon bonds can be classified according to their maturity, which is the date when Procyon has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Procyon Predictive Daily Indicators

Procyon intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Procyon pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Procyon Forecast Models

Procyon's time-series forecasting models are one of many Procyon's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Procyon's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Procyon without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Funds Screener Now

   

Funds Screener

Find actively-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module

Other Information on Investing in Procyon Pink Sheet

Procyon financial ratios help investors to determine whether Procyon Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Procyon with respect to the benefits of owning Procyon security.